» Articles » PMID: 38591997

Combining Anatomical and Biochemical Markers in the Detection and Risk Stratification of Coronary Artery Disease

Abstract

Aims: We aimed to test the hypothesis if combining coronary artery calcium score (Ca-score) as a quantitative anatomical marker of coronary atherosclerosis with high-sensitivity cardiac troponin as a quantitative biochemical marker of myocardial injury provided incremental value in the detection of functionally relevant coronary artery disease (fCAD) and risk stratification.

Methods And Results: Consecutive patients undergoing myocardial perfusion single-photon emission computed tomography (MPS) without prior CAD were enrolled. The diagnosis of fCAD was based on the presence of ischaemia on MPS and coronary angiography; fCAD was centrally adjudicated in the diagnostic and prognostic domain. Diagnostic accuracy was evaluated using the area under the receiver-operating characteristic curve (AUC). The composite of cardiovascular death and non-fatal acute myocardial infarction (AMI) within 730 days was the primary prognostic endpoint. Among 1715 patients eligible for the diagnostic analysis, 399 patients had fCAD. The combination of Ca-score and high-sensitivity cardiac troponin T (hs-cTnT) had good diagnostic accuracy for the diagnosis of fCAD (AUC 0.79, 95% confidence interval (CI) 0.77-0.81), but no incremental value compared with the Ca-score alone (AUC 0.79, 95% CI 0.77-0.81, P = 0.965). Similar results were observed using high-sensitivity cardiac troponin I (AUC 0.80, 95% CI 0.77-0.82) instead of hs-cTnT. Among 1709 patients (99.7%) with available follow-up, 59 patients (3.5%) suffered the composite primary prognostic endpoint (non-fatal AMI, n = 34; CV death, n = 28). Both Ca-score and hs-cTnT had independent prognostic value. Increased risk was restricted to patients with elevation in both markers.

Conclusion: The combination of the Ca-score with hs-cTnT increases the prognostic accuracy for future events but does not provide incremental value vs. the Ca-score alone for the diagnosis of fCAD.

Study Registration: Clinical trial registration: NCT00470587.

References
1.
Mittal T, Pottle A, Nicol E, Barbir M, Ariff B, Mirsadraee S . Prevalence of obstructive coronary artery disease and prognosis in patients with stable symptoms and a zero-coronary calcium score. Eur Heart J Cardiovasc Imaging. 2017; 18(8):922-929. PMC: 5837484. DOI: 10.1093/ehjci/jex037. View

2.
Walter J, Tanglay Y, du Fay de Lavallaz J, Strebel I, Boeddinghaus J, Twerenbold R . Clinical utility of circulating interleukin-6 concentrations in the detection of functionally relevant coronary artery disease. Int J Cardiol. 2018; 275:20-25. DOI: 10.1016/j.ijcard.2018.10.029. View

3.
Laufer E, Mingels A, Winkens M, Joosen I, Schellings M, Leiner T . The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol. 2010; 30(6):1269-75. DOI: 10.1161/ATVBAHA.109.200394. View

4.
Kim B, Choi S, Lee S, Kim C, Ryu W, Han M . Advanced coronary artery calcification is associated with ischemic stroke. Cerebrovasc Dis. 2010; 30(1):93-100. DOI: 10.1159/000314711. View

5.
Hermann D, Gronewold J, Lehmann N, Moebus S, Jockel K, Bauer M . Coronary artery calcification is an independent stroke predictor in the general population. Stroke. 2013; 44(4):1008-13. DOI: 10.1161/STROKEAHA.111.678078. View